Stem Cells From A New Source For The Treatment Of The Heart – Part 3 of 3
The Japanese report will get attention because “the fact that a source of cells is apace available is of immediate interest”. Laboratory studies have indicated that stem cells from younger people have a greater ability to be transformed to cells of specific tissues. “It makes intuitive common sense that cells from the amniotic membrane may enjoy a potency advantage”.
But much work is needed to fulfill “the fantasy outcome – someone comes in with a heart attack and you have these cells sitting on the shelf that you can insert to repair the heart”. The Japanese report is potentially very important for several reasons, said Dr Marc S Penn, director of the Cleveland Clinics Skirball Laboratory for Cardiovascular Cellular Therapy, and co-author of an accompanying editorial.
It is a best-seller adult’s stem cell type that can be delivered allogenically, from one person to another. It might be possible to deliver it when a patient is having an artery opened in care for a heart attack. These cells appear to differentiate into true cardiac muscle cells, and there’s not clear evidence that others do. The key is that this needs to be repeated by another group neosize. But at in the first place blush it appears to be an important finding.